Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) On January 17, 2023, Modular Medical, Inc. (the "Company") held its annual meeting of shareholders for the fiscal year ended March 31, 2022 (the "Annual Meeting"), and a quorum for the transaction of business was present in person virtually or represented by proxy. The Company's shareholders voted on six proposals, which are described in more detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on December 20, 2022.

(b) Voting results were as follows:





   · Proposal 1 - Election of directors to serve until the next annual meeting of
     shareholders.




                         For         Withheld       Broker Non-Vote
Paul DiPerna           6,316,874        24,074             1,473,940
William Febbo          6,223,061       118,517             1,473,940
Steven Felsher         6,085,541       256,037             1,473,940
Morgan Frank           6,316,874        24,074             1,473,940
Philip Sheibley        6,337,468         4,110             1,473,940
Carmen Volkart         6,232,034       109,544             1,473,940
Ellen O'Connor Vos     6,060,874       280,704             1,473,940

All of the foregoing candidates were elected to serve as directors until the next annual meeting of shareholders and until the election and qualification of her or his successor or earlier resignation or removal.





   · Proposal 2 - Amendment of the Amended 2017 Equity Incentive Plan to increase
     the number of shares currently reserved for issuance thereunder by 2,000,000
     shares.




   For       Against      Abstain       Broker Non-Vote
6,135,990     156,846       48,742             1,437,940




   · Proposal 3 - Approval, on an advisory basis, of the executive compensation of
     the Company's named executive officers.




   For      Against      Abstain       Broker Non-Vote
6,263,648     28,468       49,462             1,473,940




   · Proposal 4 - Recommendation, on a non-binding advisory basis, on the
     frequency of future advisory votes on the compensation of the Company's named
     executive officers.




One Year    Two Years      Three Years       Abstain
671,818          4,799        5,664,961             -




   · Proposal 5 - Ratification of the audit committee's appointment of Farber Hass
     Hurley LLP as the Company's independent registered public accounting firm for
     the fiscal year ending March 31, 2023.




   For       Against       Abstain       Broker Non-Vote
7,814,759          39           720                     -




  · Proposal 6 - Approval of one or more adjournments of the Annual Meeting.




   For       Against       Abstain       Broker Non-Vote
7,659,802     155,549           167                     -

On the basis of the voting results, the proposals to (i) amend the Amended 2017 Equity Incentive Plan to increase the number of shares currently reserved for issuance thereunder by 2,000,000 shares; and (ii) ratify the audit committee's appointment of Farber Hass Hurley LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2023 were adopted.

On the basis of the voting results, shareholders also voted a sufficient number of non-binding advisory votes to recommend that the frequency of the advisory vote on the compensation of the Company's named executive officers be held every 3 years and approve, on an advisory basis, the compensation of the Company's named executive officers.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits:


Exhibit No.   Description

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses